New Zealand markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
52.47+1.82 (+3.59%)
At close: 04:03PM EDT
52.46 -0.01 (-0.02%)
After hours: 04:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 282.79B
Enterprise value 293.94B
Trailing P/E 11.35
Forward P/E 7.40
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.13
Price/book (mrq)3.43
Enterprise value/revenue 3.18
Enterprise value/EBITDA 8.62

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 326.78%
S&P500 52-week change 3-6.14%
52-week high 361.71
52-week low 338.48
50-day moving average 351.26
200-day moving average 349.78

Share statistics

Avg vol (3-month) 328.04M
Avg vol (10-day) 323.93M
Shares outstanding 55.61B
Implied shares outstanding 6N/A
Float 85.61B
% held by insiders 10.04%
% held by institutions 169.43%
Shares short (28 Apr 2022) 467.99M
Short ratio (28 Apr 2022) 42.71
Short % of float (28 Apr 2022) 41.20%
Short % of shares outstanding (28 Apr 2022) 41.20%
Shares short (prior month 30 Mar 2022) 461.56M

Dividends & splits

Forward annual dividend rate 41.6
Forward annual dividend yield 43.17%
Trailing annual dividend rate 31.57
Trailing annual dividend yield 33.10%
5-year average dividend yield 43.64
Payout ratio 435.36%
Dividend date 309 Jun 2022
Ex-dividend date 411 May 2022
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)02 Apr 2022


Profit margin 27.01%
Operating margin (ttm)34.66%

Management effectiveness

Return on assets (ttm)11.69%
Return on equity (ttm)33.59%

Income statement

Revenue (ttm)92.43B
Revenue per share (ttm)16.48
Quarterly revenue growth (yoy)76.80%
Gross profit (ttm)50.63B
Net income avi to common (ttm)25.41B
Diluted EPS (ttm)4.36
Quarterly earnings growth (yoy)61.20%

Balance sheet

Total cash (mrq)23.9B
Total cash per share (mrq)4.26
Total debt (mrq)36.44B
Total debt/equity (mrq)44.07
Current ratio (mrq)1.39
Book value per share (mrq)14.74

Cash flow statement

Operating cash flow (ttm)34.58B
Levered free cash flow (ttm)34.29B